Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
From MaRDI portal
Publication:2219787
DOI10.1016/j.jtbi.2007.04.014zbMath1455.92087WikidataQ36492224 ScholiaQ36492224MaRDI QIDQ2219787
Michael A. Gilchrist, Libin Rong, Alan S. Perelson, Zhilan Feng
Publication date: 21 January 2021
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc2265667
92C60: Medical epidemiology
Related Items
Stability of a CD4+ T cell viral infection model with diffusion, Unnamed Item, Accounting for multi-delay effects in an HIV-1 infection model with saturated infection rate, recovery and proliferation of host cells, Stability and Hopf bifurcation of HIV-1 model with Holling II infection rate and immune delay, Stability analysis and numerical simulations of spatiotemporal HIV CD4+ T cell model with drug therapy, Vectored Immunoprophylaxis and Cell-to-Cell Transmission in HIV Dynamics, Modeling the Effect of Reactive Oxygen Species and CTL Immune Response on HIV Dynamics, Stability and bifurcation analysis of an HIV-1 infection model with a general incidence and CTL immune response, Analysis and optimal control of an HIV model with logistic growth and infected cells in eclipse phase, Unnamed Item, Stability and bifurcation analysis of a fractional‐order model of cell‐to‐cell spread of HIV‐1 with a discrete time delay, Time-adaptive determination of drug efficacy in mathematical model of HIV infection, Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profile, Dynamics of an HIV model with multiple infection stages and treatment with different drug classes, An HIV infection model based on a vectored immunoprophylaxis experiment, Immune response in virus model structured by cell infection-age, A fractional-order model of HIV infection with drug therapy effect, Complete classification of global dynamics of a virus model with immune responses, Emerging disease dynamics in a model coupling within-host and between-host systems, Global dynamics for viral infection model with Beddington-Deangelis functional response and an eclipse stage of infected cells, Global stability for an HIV-1 infection model including an eclipse stage of infected cells, The modeling dynamics of HIV and CD4\(^{+}\) T-cells during primary infection in fractional order: numerical simulation, Coupled within-host and between-host dynamics and evolution of virulence, Modeling HIV persistence, the latent reservoir, and viral blips, Spatiotemporal dynamics of an HIV infection model with delay in immune response activation, A discrete-time analog for coupled within-host and between-host dynamics in environmentally driven infectious disease, Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection, Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance, Study of HIV mathematical model under nonsingular kernel type derivative of fractional order, Structure preserving numerical analysis of HIV and CD4+T-cells reaction diffusion model in two space dimensions, Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative, Global dynamics of an age-structured model for HIV viral dynamics with latently infected T cells, The global dynamics in a wild-type and drug-resistant HIV infection model with saturated incidence, A within-host drug resistance model with continuous state-dependent viral strains, Numerical solution with analysis of HIV/AIDS dynamics model with effect of fusion and cure rate, On the well-posedness of a fractional model of HIV infection, Global dynamics for a drug-sensitive and drug-resistant mixed strains of HIV infection model with saturated incidence and distributed delays, Modeling and stability analysis of HIV-1 as a time delay fuzzy T-S system via LMIs, The threshold for a stochastic HIV-1 infection model with Beddington-DeAngelis incidence rate, A delay-dependent model with HIV drug resistance during therapy, Mathematical modeling of viral infection dynamics in spherical organs, Analysis of a CD4\(^+\) T cell viral infection model with a class of saturated infection rate, Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects, Global dynamics of a delay virus model with recruitment and saturation effects of immune responses, Modeling the dynamics of HIV and \(CD4^{+}\)T cells during primary infection, Dynamic analysis of a fractional-order model for HIV with drug-resistance and CTL immune response, Stationary distribution and extinction of a stochastic HLIV model with viral production and Ornstein-Uhlenbeck process, Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense, Approximate Analytical Solution of a HIV/AIDS Dynamic Model During Primary Infection, The effect of delay in viral production in within-host models during early infection
Cites Work
- Unnamed Item
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Optimal viral production
- Understanding drug resistance for monotherapy treatment of HIV infection
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- Mathematical analysis of delay differential equation models of HIV-1 infection
- An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells
- Dynamics of HIV infection of CD4\(^ +\) T cells
- A model for treatment strategy in the chemotherapy of AIDS
- A model of HIV-1 pathogenesis that includes an intracellular delay
- Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
- Optimizing within-host viral fitness: infected cell lifespan and virion production rate
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Production of resistant HIV mutants during antiretroviral therapy
- Mathematical Analysis of Age‐Structured HIV‐1 Dynamics with Combination Antiretroviral Therapy
- TREATMENT INTERRUPTIONS AND RESISTANCE: A REVIEW
